공지사항
NOTICE

NEWS

제목 ams and Senova inaugurate production line for Covid-19 (SARS-CoV-2) antibody digital rapid tests 등록일 2020.12.10 09:13
글쓴이 주)에이씨엑스

News facts:

  • - ams and Senova successfully opened a production line for lateral flow based test kits which will be used to detect antibodies from the Covid-19 (SARS-CoV-2) virus

  • - From idea to production in under nine months: production starts for highly sensitive quantitative lateral flow rapid tests to fight Covid-19 (SARS-CoV-2) pandemic

  • - The Senova GreenLight platform process the data in a secure medical cloud and

  • - The ams AS7341L allows spectrally resolved accurate read-out of lateral flow immune assays

  • - The cost-effective platform is applicable in doctor’s office and other point of care situations

 Click here for online version.